Fig. 5From: Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysisForest plot of odds ratios of treatment-related adverse events using a random-effects model of hepatocellular carcinomaBack to article page